BACKGROUND: Prospective studies have examined the association of serum and plasma carotenoids and micronutrients and breast cancer; however, to date, studies have only assessed exposure at one point in time. OBJECTIVE: This study analyzed baseline and repeated serum measurements of carotenoids, retinol, and tocopherols to assess their associations with postmenopausal breast cancer risk. DESIGN: Serum concentrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein + zeaxanthin, retinol, alpha-tocopherol, and gamma-tocopherol were measured in a 6% sample of women in the Women's Health Initiative clinical trials at baseline and at years 1, 3, and 6 and in a 1% sample of women in the observational study at baseline and at year 3. The association of baseline compounds and breast cancer risk was estimated by Cox proportional hazards models. In addition, repeated measurements were analyzed as time-dependent covariates. Of 5450 women with baseline measurements, 190 incident cases of breast cancer were ascertained over a median of 8.0 y of follow-up. RESULTS: After multivariable adjustment, risk of invasive breast cancer was inversely associated with baseline serum alpha-carotene concentrations (hazard ratio for highest compared with the lowest tertile: 0.55; 95% CI: 0.34, 0.90; P = 0.02) and positively associated with baseline lycopene (hazard ratio: 1.47; 95% CI: 0.98, 2.22; P = 0.06). Analysis of repeated measurements indicated that alpha-carotene and beta-carotene were inversely associated with breast cancer and that gamma-tocopherol was associated with increased risk. CONCLUSIONS: The present study, which was the first to assess repeated measurements of serum carotenoids and micronutrients in relation to breast cancer, adds to the evidence of an inverse association of specific carotenoids with breast cancer. The positive associations observed for lycopene and gamma-tocopherol require confirmation. This trial was registered at ClinicalTrials.gov as NCT00000611.
BACKGROUND: Prospective studies have examined the association of serum and plasma carotenoids and micronutrients and breast cancer; however, to date, studies have only assessed exposure at one point in time. OBJECTIVE: This study analyzed baseline and repeated serum measurements of carotenoids, retinol, and tocopherols to assess their associations with postmenopausal breast cancer risk. DESIGN: Serum concentrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein + zeaxanthin, retinol, alpha-tocopherol, and gamma-tocopherol were measured in a 6% sample of women in the Women's Health Initiative clinical trials at baseline and at years 1, 3, and 6 and in a 1% sample of women in the observational study at baseline and at year 3. The association of baseline compounds and breast cancer risk was estimated by Cox proportional hazards models. In addition, repeated measurements were analyzed as time-dependent covariates. Of 5450 women with baseline measurements, 190 incident cases of breast cancer were ascertained over a median of 8.0 y of follow-up. RESULTS: After multivariable adjustment, risk of invasive breast cancer was inversely associated with baseline serum alpha-carotene concentrations (hazard ratio for highest compared with the lowest tertile: 0.55; 95% CI: 0.34, 0.90; P = 0.02) and positively associated with baseline lycopene (hazard ratio: 1.47; 95% CI: 0.98, 2.22; P = 0.06). Analysis of repeated measurements indicated that alpha-carotene and beta-carotene were inversely associated with breast cancer and that gamma-tocopherol was associated with increased risk. CONCLUSIONS: The present study, which was the first to assess repeated measurements of serum carotenoids and micronutrients in relation to breast cancer, adds to the evidence of an inverse association of specific carotenoids with breast cancer. The positive associations observed for lycopene and gamma-tocopherol require confirmation. This trial was registered at ClinicalTrials.gov as NCT00000611.
Authors: Karin B Michels; Anshu P Mohllajee; Edith Roset-Bahmanyar; Gregory P Beehler; Kirsten B Moysich Journal: Cancer Date: 2007-06-15 Impact factor: 6.860
Authors: G W Comstock; A E Burke; S C Hoffman; E P Norkus; M Gross; K J Helzlsouer Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-01 Impact factor: 4.254
Authors: K Hultén; A L Van Kappel; A Winkvist; R Kaaks; G Hallmans; P Lenner; E Riboli Journal: Cancer Causes Control Date: 2001-08 Impact factor: 2.506
Authors: Reiko Sato; Kathy J Helzlsouer; Anthony J Alberg; Sandra C Hoffman; Edward P Norkus; George W Comstock Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-05 Impact factor: 4.254
Authors: A Heather Eliassen; Xiaomei Liao; Bernard Rosner; Rulla M Tamimi; Shelley S Tworoger; Susan E Hankinson Journal: Am J Clin Nutr Date: 2015-04-15 Impact factor: 7.045
Authors: Mary C Playdon; Regina G Ziegler; Joshua N Sampson; Rachael Stolzenberg-Solomon; Henry J Thompson; Melinda L Irwin; Susan T Mayne; Robert N Hoover; Steven C Moore Journal: Am J Clin Nutr Date: 2017-06-28 Impact factor: 7.045
Authors: Julia S Sisti; Sara Lindström; Peter Kraft; Rulla M Tamimi; Bernard A Rosner; Tianying Wu; Walter C Willett; A Heather Eliassen Journal: Breast Cancer Res Treat Date: 2015-04-28 Impact factor: 4.872
Authors: A Heather Eliassen; Sara J Hendrickson; Louise A Brinton; Julie E Buring; Hannia Campos; Qi Dai; Joanne F Dorgan; Adrian A Franke; Yu-tang Gao; Marc T Goodman; Göran Hallmans; Kathy J Helzlsouer; Judy Hoffman-Bolton; Kerstin Hultén; Howard D Sesso; Anne L Sowell; Rulla M Tamimi; Paolo Toniolo; Lynne R Wilkens; Anna Winkvist; Anne Zeleniuch-Jacquotte; Wei Zheng; Susan E Hankinson Journal: J Natl Cancer Inst Date: 2012-12-06 Impact factor: 13.506
Authors: Joanne F Dorgan; Seungyoun Jung; Cher M Dallal; Min Zhan; Christina A Stennett; Yuji Zhang; Richard L Eckert; Linda G Snetselaar; Linda Van Horn Journal: Cancer Causes Control Date: 2019-12-11 Impact factor: 2.506
Authors: Meira Epplein; Yurii B Shvetsov; Lynne R Wilkens; Adrian A Franke; Robert V Cooney; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel; Marc T Goodman Journal: Breast Cancer Res Date: 2009-07-20 Impact factor: 6.466